By Emily McCloskey, Manager, Policy and Legislative Affairs
Today, the National Alliance of State and Territorial AIDS Directors (NASTAD) released A Path to Policy: A Blueprint for Community Engagement and Advocacy. The toolkit is designed to assist state health departments and HIV and viral hepatitis programs build their advocacy, policy development and implementation and community engagement efforts. Continue reading
By Oscar Mairena, Manager, Viral Hepatitis/Policy and Legislative Affairs
Panelists at the NASTAD and Harm Reduction Coalition Congressional Briefing.
Last year, the Viral Hepatitis Prevention Coordinator (VHPC) in Massachusetts, Dan Church, wrote a post about the increasing rate of acute hepatitis C (HCV) infection among young persons who inject drugs in Massachusetts and the health department’s efforts to prevent new infections, identify existing cases, educate individuals vulnerable to acquisition, and enhance surveillance and data collection to better address the epidemic. Since then, more health departments have reported this trend, especially among young persons who begin using prescription opioids and transition to injecting heroin. Earlier this week, NASTAD partnered with the Harm Reduction Coalition to host a Congressional Briefing, An Emerging Epidemic: The Public Health Response to Hepatitis C Infection among Young People who Use Drugs, to bring this issue to light, educate Congressional staff and reinforce the role of public health in addressing emerging health concerns. Continue reading
By Maria Courogen, Director of the Office of Infectious Disease, Washington State Department of Health
Maria Courogen, Washington State AIDS Director, speaking at the launch of the updated Viral Hepatitis Action Plan.
In my role in Washington State, I oversee the state health department’s work in the areas of HIV, sexually transmitted diseases (STDs), tuberculosis and viral hepatitis. In my role as a member of NASTAD’s Executive Committee and Chair-Elect, I work with state health department colleagues across the country, many of whom have a similar portfolio of work, to provide leadership in the country’s response to HIV and hepatitis. As such, On April 3, I participated in an event hosted by the U.S. Department of Health and Human Services (HHS) for the release of the next iteration of the Viral Hepatitis Action Plan.
By Meico Whitlock, Senior Manager, Communications, NASTAD
Cross-posted from AIDS.gov
Last month, the National Alliance of State and Territorial AIDS Directors
(NASTAD) attended the fourth annual Plain Talk in Complex Times conference
in Arlington, Virginia. This year’s theme was “Communicating in a Time of Change.” The conference was hosted by the MAXIMUS Center for Health Literacy
in collaboration with the American Public Health Association
(APHA) and brought together leaders and decision-makers in fields such as public health, health communications, digital media, usability, accessibility, translation, interpretation, readability, design, and plain language to discuss communicating effectively with health consumers.
Sessions covered a range of topics such as writing for mobile device users, providing high quality care to linguistically diverse populations, and communicating effectively with numbers. A number of sessions also focused specifically on technology and provided helpful tips for tasks such conducting low-cost usability testing, enhancing website accessibility, producing podcasts, and graphic design for print materials. Continue reading
By Amy Killelea, Associate Director, Health Care Access, NASTAD
After a three and a half year wait – and several near-death experiences along the way – open enrollment under the Affordable Care Act (ACA) is finally here. On October 1st, 2013 the Marketplaces officially open for business, and millions of people will begin to apply for new public and private insurance coverage options. At this point, we all know the incredible opportunities to expand HIV and viral hepatitis prevention, care, and treatment that are at stake. Now is where the rubber meets the road as federal, state, and local advocates, providers, and programs roll up their sleeves and prepare for full implementation. Below are four action items the HIV and viral hepatitis community should be focusing on as we leap into open enrollment and beyond: Continue reading